Synlogic (NASDAQ:SYBX) Stock Price Passes Below 50-Day Moving Average – Here’s What Happened

Synlogic, Inc. (NASDAQ:SYBX) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.43 and traded as low as $1.34. Synlogic shares last traded at $1.39, with a volume of 7,571 shares trading hands.

Synlogic Stock Performance

The business has a 50 day moving average of $1.43 and a 200-day moving average of $1.47. The company has a market capitalization of $16.26 million, a P/E ratio of -0.33 and a beta of 0.80.

Synlogic (NASDAQ:SYBX) last announced its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.17. As a group, equities analysts forecast that Synlogic, Inc. will post -2.71 EPS for the current fiscal year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.